Author Details

Semiglazov, V F

Issue Section Title File
Vol 3, No 1 (2001) Articles Novoe v terapii raka molochnoy zhelezy: neoad\"yuvantnaya gormonoterapiya PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 5, No 3 (2003) Articles Novyy vzglyad na neoad\"yuvantnuyu khimioterapiyu raka molochnoy zhelezy (rol' navel'bina) PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 5, No 4 (2003) Articles Arimideks (anastrozol) v sravnenii s tamoksifenom v neoad\"yuvantnoy endokrinoterapii bol'nykh rakom molochnoy zhelezy PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 7, No 1 (2005) Articles Faktory prognoza pri rake molochnoy zhelezy PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 7, No 1 (2005) Articles Znachenie taksanov v neoad\"yuvantnoy terapii raka molochnoy zhelezy PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 7, No 2 (2005) Articles «Problema optimizatsii ad\"yuvantnoy endokrinnoy terapii na rannikh stadiyakh raka molochnoy zhelezy» PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 9, No 2 (2007) Articles Ad\"yuvantnaya endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 11, No 3 (2009) Articles Predoperatsionnaya (neoad\"yuvantnaya) endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 15, No 4 (2013) Articles The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature) PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 16, No 2 (2014) Articles Difficulties in treating patients with breast cancer in Russia: the resolution on the results of the Review Board PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 16, No 4 (2014) Articles Male breast cancer: review of the literature PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 17, No 1 (2015) Articles The improvement in overall survival for patients with metastatic breast cancer treated with eribulin: the resolution based on results of the expert council PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 17, No 1 (2015) Articles Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
Vol 18, No 2 (2016) Articles New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer PDF
(Rus)
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()
PDF
()

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).